Covid-19: Three companies to manufacture ventilators

NASA granted licenses to three Indian companies have got licences from to manufacture Covid-19 ventilators for serios patients. These are Alpha Design Technologies, Bharat Forge and Medha Servo Drives, according to space organisation.

The National Aeronautics and Space Administration (NASA) developed the ventilator specifically for coronavirus patients at its Jet Propulsion Laboratory (JLP) in Southern California.
VITAL, the special ventilator has been designed by the JPL engineers in a little over a month and received ‘Emergency Use Authorization’ from the Food and Drug Administration on April 30.

According to the statement of NASA, it offers a simple, affordable option for treating critical patients while freeing up traditional ventilators for those with the most severe COVID-19 symptoms. Its flexible design means it also can be modified for use in field hospitals,

Leon Alkalai, Manager of the JPL Office of Strategic Partnerships said that the “VITAL team is very excited to see their technology licenced. Our hope is to have this technology reach across the world and provide an additional source of solutions to deal with the on-going COVID-19 crisis.”

Its design is modified which uses compressed air and can be deployed by a greater range of hospitals and was recently tested at the UCLA Simulation Center in Los Angeles. A high-fidelity lung simulator tested almost 20 different ventilator settings, representing a number of scenarios that could be seen in critically ill patients in an intensive care unit.

Dr Tisha Wang, Clinical Chief of the UCLA Division of Pulmonary and Critical Care Medicine said that “VITAL performed well in simulation testing with both precise and reproducible results,”

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PGIMS recalls drug amid probe into deaths

    PGIMS recalls drug amid probe into deaths

    NPPA list brings little relief: No price cut for 25% cancer drugs

    NPPA list brings little relief: No price cut for 25% cancer drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    For Aakash Healthcare, Community People are Apples of its Eyes

    For Aakash Healthcare, Community People are Apples of its Eyes

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Yashoda Medicity: Baby takes a Giant Step in just One Year

    Yashoda Medicity: Baby takes a Giant Step in just One Year